FLUORIDE ACTION NETWORK PESTICIDE PROJECT
Return to FAN's Pesticide Homepage
Return to Sodium Fluoride Index Page
Sodium fluoride. Material Safety Data Sheet. Sigma Chemical Co.
http://www.mcb.ucdavis.edu/faculty-labs/kaplan/Safety_Info/MSDSs/sodium_fluoride.htm
Valid 08/1999 - 10/1999
Sigma Chemical Co.
P.O. Box 14508
St. Louis, MO 63178 USA
Tel: 314-771-5765
M A T E R I A L S A F E T Y D A T A S H E E T
SECTION 1. - - - - - - - - - CHEMICAL IDENTIFICATION- - - - - - - - - -
CATALOG #: S1504
NAME: SODIUM FLUORIDE CRYSTALLINE
SECTION 2. - - - - - COMPOSITION/INFORMATION ON INGREDIENTS - - - - - -
CAS #: 7681-49-4
MF: FNA
EC NO: 231-667-8
SYNONYMS
ALCOA SODIUM FLUORIDE * ANTIBULIT * CAVI-TROL * CHEMIFLUOR * CREDO *
DISODIUM DIFLUORIDE * FDA 0101 * F1-TABS * FLORIDINE * FLOROCID *
FLOZENGES * FLUORAL * FLUORIDENT * FLUORIDE, SODIUM * FLUORID SODNY
(CZECH) * FLUORIGARD * FLUORINEED * FLUORINSE * FLUORITAB * FLUOROCID
* FLUOR-O-KOTE * FLUOROL * FLUORURE DE SODIUM (FRENCH) * FLURA *
FLURA DROPS * FLURA-GEL * FLURA-LOZ * FLURCARE * FLURSOL * FUNGOL B *
GEL II * GELUTION * GLEEM * IRADICAV * KARIDIUM * KARIGEL * KARI-
RINSE * LEA-COV * LEMOFLUR * LURIDE * LURIDE LOZI-TABS * LURIDE-SF *
NAFEEN * NAFPAK * NA FRINSE * NATRIUM FLUORIDE * NCI-C55221 * NUFLUOR
* OSSALIN * OSSIN * PEDIAFLOR * PEDIDENT * PENNWHITE * PERGANTENE *
PHOS-FLUR * POINT TWO * PREDENT * RAFLUOR * RESCUE SQUAD * ROACH SALT
* SODIUM FLUORIDE CYCLIC DIMER * SODIUM FLUORURE (FRENCH) * SODIUM
HYDROFLUORIDE * SODIUM MONOFLUORIDE * SO-FLO * STAY-FLO * STUDAFLUOR *
SUPER-DENT * T-FLUORIDE * THERA-FLUR * THERA-FLUR-N * TRISODIUM
TRIFLUORIDE *
SECTION 3. - - - - - - - - - - HAZARDS IDENTIFICATION - - - - - - - - -
LABEL PRECAUTIONARY STATEMENTS
TOXIC
TOXIC IF SWALLOWED.
HARMFUL BY INHALATION AND IN CONTACT WITH SKIN.
CONTACT WITH ACIDS LIBERATES VERY TOXIC GAS.
CAUSES SEVERE IRRITATION.
TARGET ORGAN(S):
KIDNEYS
BONES
DO NOT BREATHE DUST.
WEAR SUITABLE PROTECTIVE CLOTHING.
IN CASE OF ACCIDENT OR IF YOU FEEL UNWELL, SEEK MEDICAL ADVICE
IMMEDIATELY (SHOW THE LABEL WHERE POSSIBLE).
SECTION 4. - - - - - - - - - - FIRST-AID MEASURES- - - - - - - - - - -
IN CASE OF CONTACT, IMMEDIATELY FLUSH EYES OR SKIN WITH COPIOUS
AMOUNTS OF WATER FOR AT LEAST 15 MINUTES WHILE REMOVING CONTAMINATED
CLOTHING AND SHOES.
IF INHALED, REMOVE TO FRESH AIR. IF NOT BREATHING GIVE ARTIFICIAL
RESPIRATION. IF BREATHING IS DIFFICULT, GIVE OXYGEN.
IF SWALLOWED, WASH OUT MOUTH WITH WATER PROVIDED PERSON IS CONSCIOUS.
CALL A PHYSICIAN IMMEDIATELY.
SYMPTOMS MAY BE DELAYED UP TO 24 HOURS DEPENDING UPON THE FLUORIDE
ION CONCENTRATION. PREVENTION OF ABSORPTION OF THE FLUORIDE ION IN
CASES OF INGESTION CAN BE OBTAINED BY GIVING MILK, CHEWABLE CALCIUM
CARBONATE TABLETS OR MILK OF MAGNESIA TO CONSCIOUS VICTIMS. CONDITIONS
SUCH AS HYPOCALCEMIA, HYPOMAGNESEMIA AND CARDIAC ARRHYTHMIAS SHOULD
BE MONITORED FOR, SINCE THEY CAN OCCUR AFTER EXPOSURE.
WASH CONTAMINATED CLOTHING BEFORE REUSE.
SECTION 5. - - - - - - - - - FIRE FIGHTING MEASURES - - - - - - - - - -
EXTINGUISHING MEDIA
NONCOMBUSTIBLE.
USE EXTINGUISHING MEDIA APPROPRIATE TO SURROUNDING FIRE CONDITIONS.
SPECIAL FIREFIGHTING PROCEDURES
WEAR SELF-CONTAINED BREATHING APPARATUS AND PROTECTIVE CLOTHING TO
PREVENT CONTACT WITH SKIN AND EYES.
UNUSUAL FIRE AND EXPLOSIONS HAZARDS
EMITS TOXIC FUMES UNDER FIRE CONDITIONS.
SECTION 6. - - - - - - - - ACCIDENTAL RELEASE MEASURES- - - - - - - - -
EVACUATE AREA.
WEAR SELF-CONTAINED BREATHING APPARATUS, RUBBER BOOTS AND HEAVY
RUBBER GLOVES.
SWEEP UP, PLACE IN A BAG AND HOLD FOR WASTE DISPOSAL.
AVOID RAISING DUST.
VENTILATE AREA AND WASH SPILL SITE AFTER MATERIAL PICKUP IS COMPLETE.
SECTION 7. - - - - - - - - - - HANDLING AND STORAGE- - - - - - - - - - -
REFER TO SECTION 8.
SECTION 8. - - - - - - EXPOSURE CONTROLS/PERSONAL PROTECTION- - - - - -
WEAR APPROPRIATE NIOSH/MSHA-APPROVED RESPIRATOR, CHEMICAL-RESISTANT
GLOVES, SAFETY GOGGLES, OTHER PROTECTIVE CLOTHING.
SAFETY SHOWER AND EYE BATH.
USE ONLY IN A CHEMICAL FUME HOOD.
DO NOT BREATHE DUST.
AVOID CONTACT WITH EYES, SKIN AND CLOTHING.
AVOID PROLONGED OR REPEATED EXPOSURE.
WASH THOROUGHLY AFTER HANDLING.
TOXIC.
SEVERE IRRITANT.
KEEP TIGHTLY CLOSED.
DO NOT STORE IN GLASS.
STORE IN A COOL DRY PLACE.
SECTION 9. - - - - - - - PHYSICAL AND CHEMICAL PROPERTIES - - - - - - -
APPEARANCE AND ODOR
WHITE POWDER
PHYSICAL PROPERTIES
MELTING POINT: 993 C
SPECIFIC GRAVITY: 2.558
SECTION 10. - - - - - - - - -STABILITY AND REACTIVITY - - - - - - - - -
STABILITY
STABLE.
CONDITIONS TO AVOID
HEAT
INCOMPATIBILITIES
STRONG ACIDS
GLASS
SENSITIVE TO MOISTURE
HAZARDOUS COMBUSTION OR DECOMPOSITION PRODUCTS
HYDROGEN FLUORIDE
HAZARDOUS POLYMERIZATION
WILL NOT OCCUR.
SECTION 11. - - - - - - - - - TOXICOLOGICAL INFORMATION - - - - - - - -
ACUTE EFFECTS
HARMFUL IF SWALLOWED, INHALED, OR ABSORBED THROUGH SKIN.
CAUSES SEVERE IRRITATION.
HIGH CONCENTRATIONS ARE EXTREMELY DESTRUCTIVE TO TISSUES OF THE MUCOUS
MEMBRANES AND UPPER RESPIRATORY TRACT, EYES AND SKIN.
SYMPTOMS OF EXPOSURE MAY INCLUDE BURNING SENSATION, COUGHING,
WHEEZING, LARYNGITIS, SHORTNESS OF BREATH, HEADACHE, NAUSEA AND
VOMITING.
EXPOSURE CAN CAUSE:
STOMACH PAINS, VOMITING, DIARRHEA.
PROLONGED EXPOSURE CAN CAUSE:
DAMAGE TO THE LUNGS
CHRONIC EFFECTS
THIS PRODUCT IS OR CONTAINS A COMPONENT THAT HAS BEEN REPORTED TO BE
POSSIBLY CARCINOGENIC BASED ON ITS IARC, ACGIH, NTP OR EPA
CLASSIFICATION.
TARGET ORGAN(S):
HEART, KIDNEYS
BONES
NERVES
G.I. SYSTEM
TEETH
TO THE BEST OF OUR KNOWLEDGE, THE CHEMICAL, PHYSICAL, AND
TOXICOLOGICAL PROPERTIES HAVE NOT BEEN THOROUGHLY INVESTIGATED.
ADDITIONAL INFORMATION
SYMPTOMS OF FLUORIDE OVEREXPOSURE MAY INCLUDE SALIVATION, NAUSEA,
VOMITING, ABDOMINAL PAIN, FEVER, LABORED BREATHING. FLUORIDE ION CAN
REDUCE SERUM CALCIUM LEVELS POSSIBLY CAUSING FATAL HYPOCALCEMIA.
PROLONGED EXPOSURE TO FLUORIDE DUSTS, VAPORS OR MISTS RESULTS IN
PERFORATION OF THE NASAL SEPTUM. CHRONIC EFFECTS INCLUDE EXCESSIVE
CALCIFICATION OF THE BONES, LIGAMENTS AND TENDONS.
RTECS #: WB0350000
SODIUM FLUORIDE
IRRITATION DATA
EYE-RBT 20 MG/24H MOD 28ZPAK -,20,1972
TOXICITY DATA
ORL-WMN LDLO:90 MG/KG JAMAAP 81,811,1923
ORL-WMN LDLO:360 MG/KG JAMAAP 100,97,1933
ORL-HMN LDLO:71 MG/KG 85KYAH 11,1361,1989
ORL-HMN LDLO:75 MG/KG PCOC** -,1033,1966
ORL-RAT LD50:52 MG/KG NTIS** UR-3490-95
IPR-RAT LD50:22 MG/KG XEURAQ UR-154,1951
SCU-RAT LD50:175 MG/KG OYYAA2 2,411,1968
IVN-RAT LD50:26 MG/KG TXAPA9 3,278,1961
ORL-MUS LD50:57 MG/KG SHGKA3 80,1519,1980
IPR-MUS LD50:38 MG/KG IMEMDT 27,237,1982
SCU-MUS LD50:115 UG/KG NYKZAU
68(3),55P-74P,1972
IVN-MUS LD50:50830 UG/KG IMEMDT 27,237,1982
IVN-MKY LD50:26600 UG/KG APTOA6 22,99,1965
ORL-RBT LD50:200 MG/KG JEENAI 61,751,1968
ORL-DOM LD50:100 MG/KG NEZTAF 30,199,1982
ORL-BWD LD50:110 MG/KG AECTCV 16,483,1987
TARGET ORGAN DATA
PERIPHERAL NERVE AND SENSATION (PARESTHESIA)
SENSE ORGANS AND SPECIAL SENSES (OLFACTION TUMORS)
SENSE ORGANS AND SPECIAL SENSES (PTOSIS)
SENSE ORGANS AND SPECIAL SENSES (OTHER EYE EFFECTS)
BEHAVIORAL (SOMNOLENCE)
BEHAVIORAL (TREMOR)
BEHAVIORAL (FLUID INTAKE)
BEHAVIORAL (MUSCLE WEAKNESS)
BEHAVIORAL (HEADACHE)
CARDIAC (EKG CHANGES NOT DIAGNOSTIC OF ABOVE)
LUNGS, THORAX OR RESPIRATION (CYANOSIS)
LUNGS, THORAX OR RESPIRATION (RESPIRATORY DEPRESSION)
GASTROINTESTINAL (CHANGES IN STRUCTURE OR FUNCTION OF SALIVARY GLANDS)
GASTROINTESTINAL (HYPERMOTILITY, DIARRHEA)
GASTROINTESTINAL (NAUSEA OR VOMITING)
GASTROINTESTINAL (OTHER CHANGES)
LIVER (OTHER CHANGES)
KIDNEY, URETER, BLADDER (OTHER CHANGES)
MUSCULO-SKELETAL (CHANGES IN TEETH AND SUPPORTING STRUCTURES)
MUSCULO-SKELETAL (OTHER CHANGES)
SKIN AND APPENDAGES (TUMORS)
IMMUNOLOGICAL INCLUDING ALLERGIC (INCREASED IMMUNE RESPONSE)
PATERNAL EFFECTS (SPERMATOGENESIS)
PATERNAL EFFECTS (TESTES, EPIDIDYMIS, SPERM DUCT)
EFFECTS ON FERTILITY (FEMALE FERTILITY INDEX)
EFFECTS ON FERTILITY (MALE FERTILITY INDEX)
EFFECTS ON FERTILITY (POST-IMPLANTATION MORTALITY)
EFFECTS ON FERTILITY (OTHER MEASURES OF FERTILITY)
EFFECTS ON EMBRYO OR FETUS (EXTRA EMBRYONIC STRUCTURES)
EFFECTS ON EMBRYO OR FETUS (FETAL DEATH)
SPECIFIC DEVELOPMENTAL ABNORMALITIES (CENTRAL NERVOUS SYSTEM)
SPECIFIC DEVELOPMENTAL ABNORMALITIES (SKIN AND SKIN APPENDAGES)
SPECIFIC DEVELOPMENTAL ABNORMALITIES (MUSCULOSKELETAL SYSTEM)
EFFECTS ON NEWBORN (STILLBIRTH)
EFFECTS ON NEWBORN (BEHAVIORAL)
NUTRITIONAL AND GROSS METABOLIC (WEIGHT LOSS OR DECREASED WEIGHT GAIN)
TUMORIGENIC (EQUIVOCAL TUMORIGENIC AGENT BY RTECS CRITERIA)
ONLY SELECTED REGISTRY OF TOXIC EFFECTS OF CHEMICAL SUBSTANCES
(RTECS) DATA IS PRESENTED HERE. SEE ACTUAL ENTRY IN RTECS FOR
COMPLETE INFORMATION.
SECTION 12. - - - - - - - - - ECOLOGICAL INFORMATION - - - - - - - - - -
DATA NOT YET AVAILABLE.
SECTION 13. - - - - - - - - - DISPOSAL CONSIDERATIONS - - - - - - - - -
CONTACT A LICENSED PROFESSIONAL WASTE DISPOSAL SERVICE TO DISPOSE OF
THIS MATERIAL.
OBSERVE ALL FEDERAL, STATE AND LOCAL ENVIRONMENTAL REGULATIONS.
SECTION 14. - - - - - - - - - - TRANSPORT INFORMATION - - - - - - - - -
CONTACT SIGMA CHEMICAL COMPANY FOR TRANSPORTATION INFORMATION.
SECTION 15. - - - - - - - - - REGULATORY INFORMATION - - - - - - - - - -
EUROPEAN INFORMATION
EC INDEX NO: 009-004-00-7
TOXIC
R 25
TOXIC IF SWALLOWED.
R 32
CONTACT WITH ACIDS LIBERATES VERY TOXIC GAS.
R 36/38
IRRITATING TO EYES AND SKIN.
S 22
DO NOT BREATHE DUST.
S 36
WEAR SUITABLE PROTECTIVE CLOTHING.
S 45
IN CASE OF ACCIDENT OR IF YOU FEEL UNWELL, SEEK MEDICAL ADVICE
IMMEDIATELY (SHOW THE LABEL WHERE POSSIBLE).
REVIEWS, STANDARDS, AND REGULATIONS
OEL=MAK
ACGIH TLV-TWA 2.5 MG(F)/M3 DTLVS* TLV/BEI,1997
ACGIH TLV-NOT CLASSIFIABLE AS A HUMAN CARCINOGEN DTLVS* TLV/BEI,1997
IARC CANCER REVIEW:HUMAN INADEQUATE EVIDENCE IMEMDT 27,237,1982
IARC CANCER REVIEW:ANIMAL INADEQUATE EVIDENCE IMEMDT 27,237,1982
IARC CANCER REVIEW:GROUP 3 IMSUDL 7,208,1987
EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION
FEREAC 54,7740,1989
MSHA STANDARD-AIR:TWA 2.5 MG(F)/M3
DTLVS* 3,116,1971
OSHA PEL (GEN INDU):8H TWA 2.5 MG(F)/M3
CFRGBR 29,1910.1000,1994
OSHA PEL (CONSTRUC):8H TWA 2.5 MG(F)/M3
CFRGBR 29,1926.55,1994
OSHA PEL (SHIPYARD):8H TWA 2.5 MG(F)/M3
CFRGBR 29,1915.1000,1993
OSHA PEL (FED CONT):8H TWA 2.5 MG(F)/M3
CFRGBR 41,50-204.50,1994
OEL-AUSTRALIA:TWA 2.5 MG(F)/M3 JAN 1993
OEL-BELGIUM:TWA 2.5 MG(F)/M3 JAN 1993
OEL-DENMARK:TWA 2.5 MG(F)/M3 JAN 1993
OEL-FINLAND:TWA 2.5 MG(F)/M3 JAN 1993
OEL-FRANCE:TWA 2 MG/M3 JAN 1993
OEL-FRANCE:TWA 2.5 MG(F)/M3 JAN 1993
OEL-GERMANY:TWA 2.5 MG(F)/M3 JAN 1993
OEL-HUNGARY:TWA 1 MG(F)/M3;STEL 2 MG(F)/M3 JAN 1993
OEL-THE NETHERLANDS:TWA 2.5 MG(F)/M3 JAN 1993
OEL-THE PHILIPPINES:TWA 2.5 MG(F)/M3 JAN 1993
OEL-POLAND:TWA 1 MG(F)/M3 JAN 1993
OEL-RUSSIA:TWA 0.2 MG/M3;STEL 1 MG/M3 JAN 1993
OEL-SWEDEN:TWA 2 MG(F)/M3 JAN 1993
OEL-SWITZERLAND:TWA 1.8 PPM (1.5 MG(F)/M3);STEL 9.0 PPM JAN 1993
OEL-THAILAND:TWA 2.5 MG(F)/M3 JAN 1993
OEL-TURKEY:TWA 2.5 MG(F)/M3 JAN 1993
OEL-UNITED KINGDOM:TWA 2.5 MG(F)/M3 JAN 1993
OEL IN BULGARIA, COLOMBIA, JORDAN, KOREA CHECK ACGIH TLV
OEL IN NEW ZEALAND, SINGAPORE, VIETNAM CHECK ACGIH TLV
NIOSH REL TO FLUORIDES, INORGANIC-AIR:10H TWA 2.5 MG(F)/M3
NIOSH* DHHS #92-100,1992
NOHS 1974: HZD 84425; NIS 50; TNF 3763; NOS 50; TNE 25059
NOES 1983: HZD 84425; NIS 83; TNF 3970; NOS 69; TNE 84776; TFE 26602
EPA GENETOX PROGRAM 1988, POSITIVE: D MELANOGASTER-WHOLE SEX CHROM.
LOSS
EPA GENETOX PROGRAM 1988, NEGATIVE: D MELANOGASTER-NONDISJUNCTION; N
CRASSA-ANEUPLOIDY
EPA GENETOX PROGRAM 1988, NEGATIVE: IN VIVO SCE-NONHUMAN; S CEREVISIAE
GENE CONVERSION
EPA GENETOX PROGRAM 1988, INCONCLUSIVE: D MELANOGASTER-PARTIAL SEX
CHROM. LOSS
EPA GENETOX PROGRAM 1988, INCONCLUSIVE: HISTIDINE REVERSION-AMES TEST
EPA GENETOX PROGRAM 1988, INCONCLUSIVE: D MELANOGASTER SEX-LINKED
LETHAL
EPA TSCA SECTION 8(B) CHEMICAL INVENTORY
EPA TSCA SECTION 8(D) UNPUBLISHED HEALTH/SAFETY STUDIES
EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, DECEMBER 1998
NTP CARCINOGENESIS STUDIES (ORAL);EQUIVOCAL EVIDENCE:RAT
NTPTR* NTP-TR-393,90
NTP CARCINOGENESIS STUDIES (ORAL);NO EVIDENCE:MOUSE
NTPTR* NTP-TR-393,90
SECTION 16. - - - - - - - - - - OTHER INFORMATION- - - - - - - - - - - -
THE ABOVE INFORMATION IS BELIEVED TO BE CORRECT BUT DOES NOT PURPORT TO
BE ALL INCLUSIVE AND SHALL BE USED ONLY AS A GUIDE. SIGMA, ALDRICH,
FLUKA SHALL NOT BE HELD LIABLE FOR ANY DAMAGE RESULTING FROM HANDLING
OR FROM CONTACT WITH THE ABOVE PRODUCT. SEE REVERSE SIDE OF INVOICE OR
PACKING SLIP FOR ADDITIONAL TERMS AND CONDITIONS OF SALE.
COPYRIGHT 1998 SIGMA-ALDRICH CO.
LICENSE GRANTED TO MAKE UNLIMITED PAPER COPIES FOR INTERNAL USE ONLY